Skip to main content
All lobbying filings

TIBER CREEK GROUP

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Trade organization of biotechnology companies.

 Filing 2nd Quarter - Termination
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$40,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Representation ended
May 31, 2025
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 5
  • Centers For Medicare and Medicaid Services (CMS)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Issues related to antimicrobial resistance.

Natural Resources

Issues related to the importation of non-human primates.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem